BioNTech SE BNTX
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Gross profit | $91.2M | -20% | FY ending Dec 31, 2019 |
|---|---|---|---|
| Net income | $-1.1B | -71% | FY ending Dec 31, 2025 |
| Research & development | $2.1B | -7% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 27 sales ($89.8M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 36,209 | $95.37 | $3.5M | Oct 9, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 27,000 | $92.31 | $2.5M | Oct 8, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 24,000 | $95.86 | $2.3M | Oct 7, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 21,000 | $96.81 | $2.0M | Oct 6, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 72,000 | $97.23 | $7.0M | Oct 5, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 17,000 | $96.72 | $1.6M | Oct 2, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 17,000 | $97.46 | $1.7M | Oct 1, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 32,000 | $98.12 | $3.1M | Sep 30, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 34,000 | $98.26 | $3.3M | Sep 29, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 34,000 | $98.47 | $3.3M | Sep 28, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 27,000 | $98.69 | $2.7M | Sep 25, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 39,000 | $98.99 | $3.9M | Sep 24, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 30,000 | $99.40 | $3.0M | Sep 23, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 46,000 | $100.72 | $4.6M | Sep 22, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 33,000 | $97.81 | $3.2M | Sep 21, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 30,000 | $96.22 | $2.9M | Sep 18, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 34,000 | $98.60 | $3.4M | Sep 17, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 15,000 | $96.09 | $1.4M | Sep 16, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 34,000 | $96.49 | $3.3M | Sep 15, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 41,000 | $99.45 | $4.1M | Sep 14, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 45,000 | $96.93 | $4.4M | Sep 11, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 20,500 | $96.31 | $2.0M | Sep 10, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 36,000 | $97.78 | $3.5M | Sep 9, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 37,000 | $99.20 | $3.7M | Sep 8, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 31,500 | $103.52 | $3.3M | Sep 4, 2026 |
| Ugur SahinChief Executive Officer, 10% owner | Soldpre-set plan | 45,000 | $102.85 | $4.6M | Sep 3, 2026 |
| Sierk PoettingChief Operating Officer | Sold | 50,000 | $110.56 | $5.5M | Apr 22, 2026 |
Trades by members of Congress
1 member reported 0 buys and 1 sale since Aug 7, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Val T. Hoyle D | Sold | $1,001–$15K | Aug 7, 2025 | Sep 12, 2025 | Spouse |
Latest SEC filings
- News filing (foreign) 6-K · Oct 26, 2026
- News filing (foreign) 6-K · Oct 26, 2026
- News filing (foreign) 6-K · Oct 22, 2026
- News filing (foreign) 6-K · Oct 19, 2026
- News filing (foreign) 6-K · Oct 13, 2026
- News filing (foreign) 6-K · Sep 18, 2026
- News filing (foreign) 6-K · Sep 14, 2026
- Insider plans to sell 144 · Sep 3, 2026
- News filing (foreign) 6-K · Aug 28, 2026
- News filing (foreign) 6-K · Aug 27, 2026
- News filing (foreign) 6-K · Aug 20, 2026
- News filing (foreign) 6-K · Aug 4, 2026
- News filing (foreign) 6-K · Aug 4, 2026
- News filing (foreign) 6-K · Aug 3, 2026
- News filing (foreign) 6-K · Jul 29, 2026
- News filing (foreign) 6-K · Jun 8, 2026
- News filing (foreign) 6-K · Jun 1, 2026
- News filing (foreign) 6-K · May 22, 2026
- News filing (foreign) 6-K · May 15, 2026
- Insider plans to sell 144 · May 12, 2026
- News filing (foreign) 6-K · May 7, 2026
- News filing (foreign) 6-K · May 5, 2026
- News filing (foreign) 6-K · May 5, 2026
- News filing (foreign) 6-K · Apr 13, 2026
- News filing (foreign) 6-K · Apr 2, 2026
About BioNTech SE
Business description
- Industry
- Biological Products, (No Diagnostic Substances)
- Sector
- Life Sciences
- Headquarters
- Mainz, Germany
- Incorporated in
- Germany
- Fiscal year ends
- December 31
- Exchange
- Nasdaq
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 1776985
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.